Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma

NCT01496807 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Sylatron
DRUG: Yervoy

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]